Cargando…
miR-508-3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7
Ovarian cancer is the most lethal gynecological tumor, and the 5-year survival rate is only ~40%. The poor survival rate is due to cancer diagnosis at an advanced stage, when the tumor has metastasized. A better understanding of the molecular pathogenesis of tumor growth and metastasis is needed to...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252466/ https://www.ncbi.nlm.nih.gov/pubmed/32377701 http://dx.doi.org/10.3892/ijo.2020.5055 |